2011
DOI: 10.1021/jm2004267
|View full text |Cite
|
Sign up to set email alerts
|

Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors

Abstract: Two series of novel chromone derivatives were synthesized and investigated for their ability to inhibit the activity of monoamine oxidase. The SAR data indicate that chromone derivatives with substituents in position 3 of γ-pyrone nucleus act preferably as MAO-B inhibitors, with IC(50) values in the nanomolar to micromolar range. Almost all chromone 3-carboxamides display selectivity toward MAO-B. Identical substitutions on position 2 of γ-pyrone nucleus result in complete loss of activity in both isoforms (ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

8
91
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 137 publications
(99 citation statements)
references
References 37 publications
8
91
0
Order By: Relevance
“…Potential tight-binding of inhibitors to the MAOs has been previously reported for a variety of different classes of compounds. [44][45][46][47] Since the inhibition of MAO-B by compound 4h may not to be readily reversible and 4h therefore may exhibit a degree of tight-binding to the MAO-B active site, the reversibility of MAO-B inhibition by 4h was further examined by dialysis. For this purpose MAO-B and 4h, at a concentration of 4 Â IC 50 , were preincubated for a period of 15 min and subsequently dialysed for 24 h. The residual enzyme activity was measured and compared to similar dialysis experiments performed in the absence of inhibitor and presence of the irreversible inhibitor, (R)-deprenyl.…”
Section: Since Reversibility Of Mao Inhibition Is Frequently a Considmentioning
confidence: 99%
“…Potential tight-binding of inhibitors to the MAOs has been previously reported for a variety of different classes of compounds. [44][45][46][47] Since the inhibition of MAO-B by compound 4h may not to be readily reversible and 4h therefore may exhibit a degree of tight-binding to the MAO-B active site, the reversibility of MAO-B inhibition by 4h was further examined by dialysis. For this purpose MAO-B and 4h, at a concentration of 4 Â IC 50 , were preincubated for a period of 15 min and subsequently dialysed for 24 h. The residual enzyme activity was measured and compared to similar dialysis experiments performed in the absence of inhibitor and presence of the irreversible inhibitor, (R)-deprenyl.…”
Section: Since Reversibility Of Mao Inhibition Is Frequently a Considmentioning
confidence: 99%
“…MAOs-catalyzed reaction involves the oxidation of the amine function, via the formation of an imine intermediate with a simultaneous reduction of the flavin cofactor that is reoxidized subsequently by molecular oxygen, with hydrogen peroxide release. The imine intermediate is then hydrolyzed, yielding ammonia and the corresponding aldehyde (Scheme 1) [38]. In mammals two isoforms of MAOs are present: MAO-A and MAO-B, which are distinguished based on their preference for the substrate and the sensitivity of their interaction with specific inhibitors [37].…”
Section: Monoamine Oxidase Type B (Mao-b) Inhibitorsmentioning
confidence: 99%
“…Chromone-type compounds are well-known for their variety of biological properties, that include antitumor [4][5][6][7][8][9][10][11][12][13][14][15], hepatoprotective [16], antioxidant [17][18][19][20][21], anti-inflammatory [22][23][24][25], cardioprotective [26], antimicrobial [27,28] and antiviral activities [29,30]. The vast range of biological effects associated with these structural skeletons has led to substantial research devoted to the isolation from natural resources, synthesis and transformation of chromone derivatives and also to biological evaluation with emphasis on their potential medicinal applications.…”
Section: Introductionmentioning
confidence: 99%